Table 2. Urinary cotinine, arsenic, and phthalates metabolites measured in n = 37 women undergoing cervical cancer treatment and participating in the study (µg/g creatinine).
| Analyte | Min. | 25th %tile | 50th %tile | 75th %tile | Max. | Geometric mean |
|---|---|---|---|---|---|---|
| Cotinine | <LOD | <LOD | 9.3 | 35.3 | 395.4 | 13.9 |
| Arsenic | <LOD | 7.4 | 13.2 | 20.8 | 115.4 | 13.1 |
| MBP | <LOD | <LOD | 9.8 | 22 | 295.5 | 8.8 |
| MBzP | <LOD | 1.8 | 5.4 | 10.7 | 182.9 | 5 |
| MEHP | 1.5 | 10.6 | 15.5 | 28.3 | 91.9 | 15. 8 |
| MEOHP | <LOD | <LOD | 2.8 | 8.2 | 34.1 | 3.5 |
| MEHHP | <LOD | 4.6 | 8.8 | 13.8 | 88.6 | 8.7 |
| %MEHP | 10.7 | 63.6 | 85.4 | 91.6 | 97.2 | 68.2 |
Notes.
- LOD
- method limit of detection
- MBP
- mono butyl phthalate
- MBzP
- mono benzyl phthalate
- MEHP
- mono (2-ethylhexyl) phthalate
- MEOHP
- mono (2-ethyl-5-oxohexyl) phthalate
- MEHHP
- mono (2-ethyl-5-hydroxyhexyl) phthalate
- %MEHP
- 100 × (MEHP/(MEHP + MEOHP + MEHHP) on a molar basis